Breese CR, Freedman R, Leonard SS. 1995. Glutamate receptor subtype
expression in human post-mortem brain tissue from schizophrenics and
alcohol abusers. Brain Res 674:82–90.
Burette A, Wyszynski M, Valtschanoff JG, Sheng M, Weinberg RJ. 1999.
Characterization of glutamate receptor interacting protein-immunopositive neurons in cerebellum and cerebral cortex of the albino rat.
J Comp Neurol 411:601– 612.
Burette A, Khatri L, Wyszynski M, Sheng M, Ziff EB, Weinberg RJ. 2001.
Differential cellular and subcellular localization of AMPA receptorbinding protein and glutamate receptor-interacting protein. J Neurosci
21:495–503.
Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson
ML. 2001. Interactions between monoamines, glutamate, and GABA
in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:
237–260.
Celio MR. 1986. Parvalbumin in most gamma-aminobutyric acidcontaining neurons of the rat cerebral cortex. Science 231:995–997.
Davidson M, Haroutunian V. 1995. Cognitive impairment in geriatric
schizophrenic patients: clinical and post-mortem characterization. In:
Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press.
Davidson M, Harvey PD, Powchik P, Parrella M, White L, Knobler HY,
Losonczy MF, Keefe RS, Katz S, Frecska E. 1995. Severity of symptoms
in chronically institutionalized geriatric schizophrenic patients. Am J
Psychiatry 152:197–207.
DeSouza S, Fu J, States BA, Ziff EB. 2002. Differential palmitoylation
directs the AMPA receptor-binding protein ABP to spines or to intracellular clusters. J Neurosci 22:3493–3503.
Dingledine R, Borges K, Bowie D, Traynelis SF. 1999. The glutamate
receptor ion channels. Pharmacol Rev 51:7– 61.
Dong H, O'Brien RJ, Fung ET, Lanahan AA, Worley PF, Huganir RL.
1997. GRIP: a synaptic PDZ domain-containing protein that interacts
with AMPA receptors. Nature 386:279 –284.
Dracheva S, Marras SAE, Kramer FR, Davis KL, Haroutunian V. 2001.
N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry 158:
1400 –1410.
Dracheva S, Elhakem SL, Marcus SM, Siever LJ, McGurk SR, Haroutunian
V. 2003. RNA editing and alternative splicing of human serotonin 2C
receptor in schizophrenia. J Neurochem 87:1402–1412.
Dracheva S, Elhakem SL, McGurk SR, Davis KL, Haroutunian V. 2004.
GAD67 and GAD65 mRNA and protein expression in cerebrocortical
regions of elderly patients with schizophrenia. J Neurosci Res 76:581–
592.
Eastwood SL, Porter RH, Harrison PJ. 1996. The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1,
KA2, NR1) mRNAs and glutamate binding protein mRNA in rat
forebrain. Neurosci Lett 212:163–166.
Farber NB, Newcomer JW, Olney JW. 1998. The glutamate synapse in
neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease. Prog Brain Res 116:421– 437.
Fitzgerald L, Deutch A, Gasic G, Heinemann S, Nestler E. 1995a. Regulation of cortical and subcortical glutamate receptor subunit expression by
antipsychotic drugs. J Neurosci 15:2453–2461.
Fitzgerald LW, Deutch AY, Gasic G, Heinemann SF, Nestler EJ. 1995b.
Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J Neurosci 15:2453–2461.
Gardoni F, Mauceri D, Fiorentini C, Bellone C, Missale C, Cattabeni F, Di
Luca M. 2003. CaMKII-dependent phosphorylation regulates SAP97/
NR2A interaction. J Biol Chem 278:44745– 44752.
Geiger JR, Melcher T, Koh DS, Sakmann B, Seeburg PH, Jonas P, Monyer
H. 1995. Relative abundance of subunit mRNAs determines gating and
Ca2 permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 15:193–204.
